Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
AADIAerpio Pharmaceuticals(AADI) Prnewswire·2024-08-01 04:05

Company to Host Conference Call and Webcast on August 7, 2024LOS ANGELES, July 31, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 8:30 am EDT (5:30 am PDT) to report second quarter 2024 financial results and provide recent corporate updates.Conferenc ...